[1]李德来.血清MCP-1蛋白水平对肺癌及肺结核患者诊断的临床意义[J].医学信息,2019,32(19):171-173.[doi:10.3969/j.issn.1006-1959.2019.19.057]
　LI De-lai.Clinical Significance of Serum MCP-1 Protein Level in the Diagnosis of Lung Cancer and Pulmonary Tuberculosis[J].Journal of Medical Information,2019,32(19):171-173.[doi:10.3969/j.issn.1006-1959.2019.19.057]
点击复制

血清MCP-1蛋白水平对肺癌及肺结核患者诊断的临床意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年19期
页码:
171-173
栏目:
诊疗技术
出版日期:
2019-10-01

文章信息/Info

Title:
Clinical Significance of Serum MCP-1 Protein Level in the Diagnosis of Lung Cancer and Pulmonary Tuberculosis
文章编号:
1006-1959（2019）19-0171-03
作者:
李德来
（天津中医药大学附属北辰中医医院检验科，天津 300000）
Author(s):
LI De-lai
(Department of Clinical Laboratory,Beichen Hospital of Traditional Chinese Medicine,Tianjin University ofTraditional Chinese Medicine,Tianjin 300000,China)
关键词:
单核细胞趋化蛋白-1;  肺癌;  肺结核
Keywords:
Monocyte chemoattractant protein-1; Lung cancer; Tuberculosis
分类号:
R734.2
DOI:
10.3969/j.issn.1006-1959.2019.19.057
文献标志码:
A
摘要:
目的 探讨MCP-1蛋白表达在肺癌及肺结核患者中的临床意义。方法 选取2017年1月~2018年12月我院呼吸科收治的40例肺癌及40例肺结核患者为研究对象，同时选取同期在我院体检健康人群40例为对照组，对比三组血清及PBMC上清液中MCP-1浓度及不同期、不同病理类型肺癌患者血清及PBMC上清液中MCP-1浓度和初治和复治肺结核血清及PBMC上清液中MCP-1浓度。结果 肺结核组及肺癌组血清及PBMC上清液中MCP-1浓度高于对照组，且肺结核组高于肺癌组，差异有统计学意义（P＜0.05）；晚期肺癌患者血清及PBMC上清液中MCP-1浓度分别为（152.71±12.56）pg/ml、（419.52±33.93）pg/ml，均高于早期肺癌患者的（73.21±7.90）pg/ml、（312.60±28.62）pg/ml，差异均有统计学意义（P＜0.05）；三种不同病理类型肺癌患者血清及PBMC上清液中MCP-1浓度比较，差异无统计学意义（P＞0.05）；肺结核复治患者血清及PBMC上清液中MCP-1浓度分别为（173.65±13.22）pg/ml、（520.11±67.28）pg/ml，高于肺结核初治患者的（156.21±9.13）pg/ml、（498.34±50.03）pg/ml，差异有统计学意义（P＜0.05）。结论 血清MCP-1蛋白水平于肺癌及肺结核的发生、病情发展有密切的关系，且随病情的进展会升高，临床可将其作为诊治的重要指标。
Abstract:
Objective To investigate the clinical significance of MCP-1 protein expression in patients with lung cancer and pulmonary tuberculosis. Methods 40 patients with lung cancer and 40 patients with pulmonary tuberculosis admitted to our hospital from January 2017 to December 2018 were enrolled in the study. At the same time, 40 healthy subjects in our hospital were selected as the control group,and the concentration of MCP-1 in serum and PBMC supernatant in the three groups were compared.The concentration of MCP-1 in serum and PBMC supernatant of lung cancer patients with different pathological types and the concentration of MCP-1 in serum and PBMC supernatant of newly diagnosed and retreated pulmonary tuberculosis.Results The concentration of MCP-1 in serum and PBMC supernatant of pulmonary tuberculosis group and lung cancer group was higher than that of control group, and the tuberculosis group was higher than that in lung cancer group, the difference was statistically significant (P<0.05); the concentration of MCP-1 in serum and PBMC supernatant of late stage lung cancer patients was （152.71±12.56）pg/ml、（419.52±33.93）pg/ml, which was higher than that in early stage lung cancer patients （73.21±7.90）pg/ml、（312.60±28.62）pg/ml，the difference was statistically significant (P<0.05); there was no significant difference in the concentration of MCP-1 in serum and PBMC supernatant of three different pathological types (P>0.05); the concentration of MCP-1 in serum and PBMC supernatant of retreated pulmonary tuberculosis patients was （173.65±13.22）pg/ml、（520.11±67.28）pg/ml, which was higher than that in untreated pulmonary tuberculosis patients （156.21±9.13）pg/ml、（498.34±50.03）pg/ml, the difference was statistically significant (P<0.05).Conclusion Serum MCP-1 protein level is closely related to the occurrence and development of lung cancer and tuberculosis, and it will increase with the progress of the disease. It can be used as an important indicator for diagnosis and treatment.

参考文献/References:

[1]木合塔尔·吐尔洪,楚刚辉,木尼热·阿不都克里木.新疆戈壁野生木贼麻黄中麻黄碱和盐酸伪麻黄碱含量的测定[J].南开大学学报（自然科学版）,2016,49(5):74-78. [2]黄韵然,王晓玲,谢志宏,等.盐酸伪麻黄碱/盐酸非索非那定复方缓释胶囊的研究.Ⅱ.质量研究[J].中国医药工业杂志,2016,47(4):448-453. [3]曹燕妮,李传勋,吕佳,等.HPLC法测定咳喘宁口服液中盐酸麻黄碱和盐酸伪麻黄碱的含量[J].中国民族民间医药,2017(21):22-25. [4]邱燕.HPLC法测定防风通圣颗粒中盐酸麻黄碱和盐酸伪麻黄碱含量[J].海峡药学,2018(1):75-77. [5]王博,孟乡,孟繁蕴,等.胶束毛细管电泳法同时测定小青龙颗粒中的盐酸麻黄碱、盐酸伪麻黄碱、盐酸甲基麻黄碱与芍药苷含量[J].中国药房,2019(1):45-49. [6]国家药典委员会编.中华人民共和国药典2015年版一部[M].北京:中国医药科技出版社,2015:890-892． [7]巩长芹,周利章.反相高效液相色谱法测定黄龙止咳颗粒中盐酸麻黄碱和盐酸伪麻黄碱的含量[J].中国医院用药评价与分析,2014(3):225-227.

相似文献/References:

[1]彭中华,彭诗婷,庞 河,等.CCL2调节血管生成及在骨重建修复中的运用[J].医学信息,2022,35(02):47.[doi:10.3969/j.issn.1006-1959.2022.02.012]
　PENG Zhong-hua,PENG Shi-ting,PANG He,et al.CCL2 Regulates Angiogenesis and its Application in Bone Reconstruction[J].Journal of Medical Information,2022,35(19):47.[doi:10.3969/j.issn.1006-1959.2022.02.012]

更新日期/Last Update: 2019-10-01